The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Seems very quiet right now. Keep nibbling away I guess until something exciting lands.
Yes,I guess a full HO license will be required before CEL production team can fire the starters gun.
I was the only ouside shareholder at the AGM.
are there any shareholder perks, free product perhaps??? the AGM must be fun :)
PS topped up 5k today but showing on here as a sell
From that RNS... the market will need confirmation of the renewal of the home office licence, as it expired on the 12th Jan 2023 before we see any real traction and interest.
Celadon will require receipt of confirmation from the Home Office that they have updated its current Home Office licence before they will be able to supply its GMP API to third parties. The Company is informing the Home Office of the receipt of its GMP registration. Celadon's current Home Office licence permits it to legally grow high-THC medicinal cannabis for the purpose of producing test batches of cannabis oil to support its application to the MHRA; during 2022, Celadon achieved seven successful harvests. Whilst there is no guarantee that the Home Office will update the current licence, nor any timeframe for this, the Directors are confident that the licence will be updated in due course. The Company has worked closely with the Home Office for four years, including securing updates to its licence, and had the conversation about updating the licence for GMP at the Home Office's last site inspection.
and from the proposed acquisition document dated 28th feb 2022.
On 23 July 2021, Vertigrow's subsidary, CPL received a Home Office Licence following approval from the Medicines and Healthcare products Regulatory Agency (the "MHRA") to apply for the licence, allowing it to legally grow medicinal cannabis in the UK for the purpose of producing test batches of cannabis oil to support its application to the MHRA for registration as a manufacturer of medicinal product APIs. This licence was renewed on 12 January 2022 for a 12 month period and as part of that renewal CPL changed its analytical testing partner. The process of obtaining this licensing is complex, took over two years, required material investment and is technically extensive. The Directors and Proposed Directors believe this is one of the first such Home Office Licences granted in the UK. Following the satisfactory production of test batches of cannabis oil, Celadon will apply for MHRA registration and if this is successfully received, Celadon will also apply for a new licence from the Home Office. Once received, the new Home Office licence would be required to be renewed annually. The receipt of MHRA registration and a new Home Office licence will enable the business to then supply medicinal cannabis (in the form of an API to manufacturers of finished medicinal products, which in this case is an extracted oil used in the finished pharmaceutical product) with a high THC content in the UK, allowing it an opportunity to enter what is expected to be a substantial, extensively regulated and fast-growing UK market.
Yes, I do think it is time to build a decent stake now, and I'm starting to build mine.
Can't wait to sample the products!
It will go loud soon, I wouldn't be surprised if it will bag within few days. Dyor, gla
I agree. The uncertainty and major risk of failure has been passed and the market reaction is muted.
GMP registration understood to be the first such registration of a UK pharmaceutical facility for high ?9-tetrahydrocannabinol ("THC") cannabis API since the legalisation of medical cannabis in 2018
I think the market is saying ''this is a nice story, the approval is in place and the upside is therefore considerable, but the last results show £11k turnover, and IP only has real value when it is commercialised.''
I guess I am in for a couple of years with this, and remember what happened to GWP....eventually.... after a long and rocky journey.
Market lately react after a day, or two. Only my opinion
Is there enough cash to 2024 when revenues start or they need more? I think the market is saying "more"
Somewhat disappointing market reaction to the positive news; this will take time, but I think there is huge upside.
Bit of interest here today
Nice article written yesterday
https:// www . europeanbusinessreview . com/top-4-pharmaceutical-stocks-to-watch-this-year
It's getting ready to launch.
New firm waiting at the starting block.
Yes, waiting for go ahead with MHRA.
ceo,on sky news atm
Caparo Energy (CEL) is a sell with the drop through the stoploss at 90.35 and support to new lows. Sell. Says David Linton
Ravi Kailas, Caparo Energy's Chairman and Chief Executive Officer, commented: "The closing of the second tranche of mezzanine financing in a timely manner puts our company in a position to fund over 700 MW of wind projects without any dilution to existing shareholders. We are also pleased with the strengthening of our management team with people who have a proven track record in the industry. By placing 360 MW of orders with Suzlon for delivery by March 2012, the Company demonstrates again its ability to build utility scale wind power projects with an unprecedented efficiency. "As the Company's transformative growth continues, its identity has also evolved. Accordingly, the Company is proposing to change it's name to Mytrah Energy Limited and we are excited by the Company's prospects of trading under this new identity. The Board would like to re-iterate its gratitude to have begun as Caparo Energy and would like to thank the Caparo Group for their on-going support to the Company."
Purchase orders for 260 MW placed with Suzlon Since our previous announcement, CEIL has placed specific purchase orders with Suzlon Energy Limited ("Suzlon") for a further 260 MW of wind projects for delivery by March 2012. When combined with the 100 MW ordered in February 2011, CEIL's total purchase orders have grown to 360 MW, of which 52 MW have already been commissioned, with the balance expected to be commissioned in stages by March 2012. The Company will release further updates of orders being placed for delivery by March 2012 in due course. The new purchase orders for 260 MW cover five individual projects located in the states of Maharashtra, Gujarat, Karnataka and Rajasthan. All of these sites have wind data using a met mast measured at different heights for an average period of over four years and are fully permitted. The Company has selected these sites based on detailed analysis and independent wind studies completed by internationally recognised firms in this field, and the Board is confident that these projects represent some of the best sites being commissioned in India over the next two years and that the Plant Load Factors ("PLF") for these sites are very attractive. Following the placing of these orders, which are ahead of the schedule previously announced, the Board anticipates that by March 2012 the Company will have a total of 500 MW of fully operational projects connected to the grid and generating cash flow. Additionally, the Board expects to achieve the full 1 GW of project orders with Suzlon by March 2013.
Closed Second Tranche of Mezzanine: The Board of Directors of Caparo Energy (the "Board") is pleased to announce that Caparo Energy (India) Limited ("CEIL"), the Company's wholly owned subsidiary, has closed a second tranche of mezzanine funding. This second tranche of mezzanine financing, which is for a 4 year term, of Rs. 1,500m (US$33.5m) is being provided by the Infrastructure Development Finance Company Limited ("IDFC"). As stated in the Company's previous announcement of 20 June 2011, the terms of both tranches of mezzanine financing entail no equity dilution for Caparo Energy's existing shareholders. The Board believes that this will result in enhanced equity returns for investors. The Company expects to repurchase/buy-back both tranches of mezzanine from internal cash flows and the issue of senior debt instruments, bonds or other debt refinancing, within three to five years. The Board believes that securing these two tranches of financing, totalling Rs 5,000 (US$112m), is a significant step forward for the business and anticipates that this additional funding, along with the Company's existing resources, would enable the Company to develop approximately 700 MW of wind projects.
http://www.investegate.co.uk/Article.aspx?id=201108100700100643M
Ravi Kailas, Caparo Energy's Chief Executive Officer, commented: "The commissioning of the first projects and the securing of mezzanine financing are two extremely important milestones, both of which the Company achieved ahead of a very tight schedule. This financing, together with the second tranche expected to be secured shortly, puts the Company in a position to fund approximately 700 MW of projects, with no further equity dilution to the existing shareholders and we extend a warm welcome our new investors. "Caparo Energy's strong relationship with Suzlon has also enabled us to identify an attractive portfolio of additional wind projects totalling 750 MW for delivery by March 2013. This takes our portfolio of projects with Sulzon to 850 MW and we are confident that we will meet our target 1GW by March 2013. "With India's continued power deficit and the increased price of coal, wind power is rapidly becoming a cost effective and mainstream source of power and Caparo Energy is well positioned to lead this transformation which is taking place in the Indian power infrastructure."
The board of directors of Caparo Energy (the "Board") is pleased to announce a number of important developments in connection with the Company's financing and operations: Highlights: Secured US$78.5m of Mezzanine finance without equity dilution In advanced stage of negotiations for an additional US$33.5m mezzanine finance on similar terms Following the commitment of the second tranche of finance, the Company believes it will have sufficient funds for the development of approximately 700 MW of wind projects First 10.5 MW in Rajasthan connected to the grid and revenue generating with a further 31.5 MW to be connected by mid-July 2011 Agreement with Suzlon on sites for further 750 MW to be delivered by March 2013, of which 400 MW of orders, due for delivery by March 2012, are expected to be placed ahead of schedule